NuVasive | Marktkapitalisierung



Marktkapitalisierung Veränderung Datum
Abbott USD 217.86B 15.25B 2025-12
AtriCure USD 1.61B 360M 2026-02
Baxter International USD 9.54B 279M 2026-02
Becton, Dickinson and Co. USD 51.01B 4.28B 2026-02
Boston Scientific USD 110.32B 31.04B 2026-02
Cooper Companies USD 13.9B 205M 2025-09
Dexcom USD 25.44B 449M 2026-02
Edwards Lifesciences USD 44.75B 4.72B 2026-02
Globus Medical USD 12.44B 752M 2026-02
Haemonetics USD 3.3B 456M 2026-02
Hologic USD 16.62B 1.67B 2025-12
Inogen USD 121M 146M 2023-09
Insulet USD 18.05B 1.95B 2026-02
Integra LifeSciences USD 886M 81M 2026-02
Intuitive Surgical USD 200.77B 40.45B 2025-12
J&J USD 500.24B 67.44B 2025-12
Medtronic USD 118.67B 10.66B 2026-02
Merit Medical Systems USD 4.78B 451M 2026-02
Orthofix International USD 473M 187M 2023-09
Stryker USD 134.41B 6.92B 2025-12
Tandem Diabetes Care USD 1.21B 278M 2026-02
Teleflex USD 5.6B 207M 2026-02
Zimmer Biomet Holdings USD 19.82B 2B 2026-02


NuVasive Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2026.